VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Beth Israel Medical Center, New York

St Lukes-Roosevelt Hospital, New York

Memorial Sloan Kettering Cancer Center, New York

New York Hospital Cornell Medical Center, New York

University of Rochester Medical Center, Rochester

Western Pennsylvania Hospital, Pittsburgh

University of Pennsylvania Cancer Center, Philadelphia

Fox Chase Cancer Center, Philadelphia

Georgetown University Medical Center Lombardi Cancer Center, Washington D.C.

Wake Forest, University health Sciences/Comprehensive Cancer Center, Winston-Salem

University of North Carolina, Chapel Hill

The Emory Clinic, Atlanta

H. Lee Moffitt Cancer Center & Research Institute, Tampa

University of Alabama, Birmingham

Vanderbilt University, Nashville

Indiana University Cancer Center, Indianapolis

University of Iowa Hospital Division, Iowa City

University Hospital-Madison Wisconsin, Madison

North Memorial Hospital, Robbinsdale

The Rush Cancer Center, Chicago

University of Chicago Medical Center, Chicago

Onc/Hem Associates of Kansas City, Kansas City

University of Nebraska Medical Center, Omaha

Cancer Care Associates, Oklahoma City

Cancer Care Associates, Tulsa

MD Anderson Cancer Center, Houston

University of Colorado Cancer, Denver

UCLA School of Medicine, Los Angeles

Loma Linda Cancer Research Institute, Loma Linda

Stanford University, Palo Alto

Alta Bates Medical Center, Berkeley

Oregon Health Science University, Portland

City of Hope Comprehensive Cancer Center, Duarte

Dartmouth-Hitchcock Medical Center, Lebanon

Sarah Cannon Cancer Center, Nashville